Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): A better mousetrap? A review of the clinical evidence-Reference-Cited by-同舟云学术

Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): A better mousetrap? A review of the clinical evidence

Published:2012-09 Issue:3 Volume:83 Page:407-421
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Ou Sai-Hong Ignatius

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference117 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world;Kamangar;J Clin Oncol,2006

3. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

4. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

5. Cancer facts & figures, 2010;American Cancer Society,2010

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, docking studies, in silico ADMET predictions, DFT calculations, and photophysical properties of thiazole-anthracene hybrids as potent EGFR inhibitors;Journal of Molecular Structure;2024-12

2. Appraisal and synthesis of novel indole-thiazole derivatives as epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitors against resistance mutation for lung cancer treatment;Results in Chemistry;2024-10

3. Synthesis and anti-breast cancer evaluation of fused imidazole-imidazo[1,2-c][1,2,3]triazoles: PEG-400 mediated one-pot reaction under ultrasonic irradiation;Journal of Molecular Structure;2024-09

4. FDA-approved small molecule kinase inhibitors for cancer treatment (2001–2015): Medical indication, structural optimization, and binding mode Part I;Bioorganic & Medicinal Chemistry;2024-09

5. Structure-Based Design and Discovery of a Potent and Cell-Active LC3A/B Covalent Inhibitor;Journal of Medicinal Chemistry;2024-07-16